Epithelialization in Wound Healing: Phases, Mechanisms, and Clinical Importance

Epithelialization is a fundamental biological process involved in the restoration of the epithelial barrier following tissue injury. It is characterized by the coordinated migration, proliferation, and differentiation of keratinocytes and other epithelial cells to re-establish skin integrity and homeostasis. This process plays a critical role in cutaneous wound healing, where the rapid reformation of the epidermal layer is essential for protecting underlying tissues from environmental insults, infection, and fluid loss.

In this blog post, we will explore the cellular and molecular mechanisms underlying epithelialization, detail the key phases of the process, examine factors that regulate or impair it—particularly in chronic wound environments—and discuss therapeutic strategies that aim to enhance epithelial repair.

What Is Epithelialization?

Epithelialization refers to the regenerative process through which epithelial cells migrate, proliferate, and differentiate to restore the integrity of an epithelial surface following injury. In the context of cutaneous wound healing, it specifically involves the reformation of the epidermis over a wound bed, re-establishing the skin’s barrier function.

At the cellular level, epithelialization is predominantly mediated by keratinocytes, the major cell type of the epidermis. Upon injury, basal keratinocytes located at the wound margins become activated and undergo phenotypic changes that enhance their migratory capacity. These cells detach from the basement membrane, reorganize their cytoskeleton (notably actin filaments), and begin to migrate across the provisional wound matrix composed of fibrin and fibronectin.

This migration is followed by proliferation, where keratinocytes divide to repopulate the wound area. The final step involves stratification and differentiation, during which the newly formed basal layer gives rise to the suprabasal layers of the epidermis, restoring the skin’s normal architecture.

Importantly, epithelialization is tightly coordinated with other phases of wound healing—particularly inflammation, granulation tissue formation, and matrix remodeling. It requires the interaction of multiple growth factors (such as EGF, TGF-α, and KGF), cytokines, and extracellular matrix (ECM) components that collectively modulate cellular behavior.

Epithelialization is distinct from, yet dependent on, underlying processes like angiogenesis, fibroblast activity, and matrix deposition. While granulation tissue provides the scaffold for migration, the integrity of the basement membrane and ECM adhesion molecules (e.g., integrins) are critical for successful re-epithelialization.

Failure or delay in epithelialization, often observed in chronic wounds (e.g., diabetic ulcers), is a major barrier to wound resolution and is the focus of ongoing translational research in regenerative medicine and tissue engineering.

The Role of Epithelial Cells in Wound Healing

Epithelial cells—particularly keratinocytes in the skin—are central players in the wound healing process, acting as the primary agents responsible for restoring the epidermal barrier after injury. Their role extends beyond mere coverage of the wound surface; they participate in a highly regulated sequence of events that includes migration, proliferation, differentiation, and cross-talk with immune and stromal cells.

1. Activation and Migration

Following injury, keratinocytes at the wound edge undergo activation triggered by inflammatory cytokines (e.g., IL-1β, TNF-α) and growth factors such as epidermal growth factor (EGF), keratinocyte growth factor (KGF/FGF7), and transforming growth factor-α (TGF-α). This activation leads to downregulation of cell–cell adhesion molecules (e.g., E-cadherin) and upregulation of motility-related proteins.

Activated keratinocytes extend lamellipodia and migrate over the provisional extracellular matrix (ECM)—rich in fibronectin, vitronectin, and fibrin—secreted by platelets and fibroblasts. This migration is integrin-mediated, particularly involving α5β1 and αvβ6 integrins, which connect the cytoskeleton to ECM proteins and facilitate directional movement.

2. Proliferation and Expansion

As migration progresses, proliferation of keratinocytes is initiated to expand the epithelial cell population and cover the denuded area. Mitogenic signals from EGF and FGF stimulate cell cycle progression, especially in basal keratinocytes. Stem/progenitor cells located in the basal layer of the epidermis and hair follicle bulge are also mobilized to supply new cells.

This phase is energy-intensive and tightly regulated by cyclins, cyclin-dependent kinases (CDKs), and transcription factors such as p63, which governs epithelial stemness and regenerative capacity.

3. Differentiation and Stratification

Once the migrating epithelial tongue meets its counterpart from the opposite wound edge, cell migration halts (a phenomenon known as contact inhibition), and cells begin to differentiate to restore the stratified architecture of the epidermis. This involves upward migration of cells, expression of differentiation markers (e.g., involucrin, filaggrin, loricrin), and re-establishment of tight junctions and desmosomes.

4. Crosstalk with Other Cell Types

Epithelial cells also engage in dynamic interactions with fibroblasts, immune cells, and endothelial cells. For example, keratinocyte-derived signals like IL-8 and GM-CSF recruit neutrophils and macrophages, while fibroblast-secreted KGF promotes epithelial proliferation. This bidirectional communication ensures synchronization between epithelialization, angiogenesis, and matrix remodeling.

Stages of Epithelialization

Epithelialization unfolds as a tightly regulated, multistep process that parallels and overlaps with the classical phases of wound healing: hemostasis, inflammation, proliferation, and remodeling. While epithelialization is most active during the proliferative phase, it involves distinct cellular and molecular events that progress in a defined sequence. The major stages of epithelialization are:

1. Keratinocyte Activation and Detachment

Shortly after injury, keratinocytes at the wound margins are exposed to pro-inflammatory cytokines (e.g., IL-1, TNF-α), DAMPs (damage-associated molecular patterns), and reactive oxygen species generated during the inflammatory phase. These cues trigger keratinocyte activation, leading to:

• Downregulation of adhesion molecules (e.g., E-cadherin)
• Cytoskeletal reorganization (via Rho GTPases and actin polymerization)
• Induction of matrix metalloproteinases (MMPs) to degrade local ECM and basement membrane

This prepares the epithelial cells for migration into the wound bed.

2. Migration Across the Wound Bed

Activated keratinocytes migrate over the provisional matrix composed of fibrin, fibronectin, and vitronectin. This process involves:

• Lamellipodia extension driven by actin dynamics
• Integrin-mediated adhesion (notably α5β1 and αvβ6)
• Use of focal adhesions to generate traction forces

Migration proceeds as a collective movement, with leader cells at the front edge sensing chemotactic and haptotactic cues and trailing cells following via intercellular junctions.

3. Proliferation and Epithelial Expansion

As keratinocytes migrate, proliferation is initiated behind the migrating front to ensure a sufficient number of cells to re-epithelialize the wound. This is driven by mitogenic signals such as:

• EGF and KGF signaling through EGFR and FGFR2b
• Activation of MAPK and PI3K/AKT pathways
• Involvement of transcription factors like c-Myc and p63

Stem/progenitor cells from the basal layer and skin appendages (e.g., hair follicles) contribute to this expansion.

4. Differentiation and Stratification

Once epithelial tongues from opposite sides of the wound meet, keratinocyte migration halts due to contact inhibition. At this point:

• Keratinocytes exit the cell cycle
• Initiate terminal differentiation, forming the suprabasal layers
• Express key structural proteins: involucrin, filaggrin, loricrin
• Re-establishment of desmosomes, tight junctions, and lipid barriers

This stage reconstitutes the full stratified squamous epithelium and restores barrier function.

5. Remodeling of the Basement Membrane and ECM

As epithelialization concludes, the basement membrane is reformed, guided by contributions from both epithelial and dermal cells. Key components include:

• Type IV collagen
• Laminin-332
• Nidogen and perlecan

These elements re-anchor the basal layer and finalize the epithelial–mesenchymal interface.

Key Factors Influencing Epithelialization

Epithelialization is a complex biological process governed by a multifaceted interplay of cellular, molecular, and environmental factors. These elements collectively modulate keratinocyte behavior—activation, migration, proliferation, and differentiation—thereby determining the speed and quality of epidermal regeneration. Disruption in any of these regulatory components can result in impaired epithelial repair, commonly observed in chronic wounds and pathological skin conditions.

Below are the key categories of factors that influence epithelialization:

1. Growth Factors

Growth factors are critical modulators of epithelial cell proliferation, migration, and survival. Several members of the EGF family and fibroblast growth factor family are particularly important:

• Epidermal Growth Factor (EGF): Binds EGFR, activates MAPK/ERK and PI3K/AKT pathways to promote keratinocyte migration and proliferation.
• Keratinocyte Growth Factor (KGF/FGF7): Secreted by fibroblasts; enhances keratinocyte proliferation and differentiation.
• Transforming Growth Factor-α (TGF-α): Similar to EGF in function; plays a role in epithelial sheet expansion.
• Hepatocyte Growth Factor (HGF): Modulates motility and morphogenesis of epithelial cells through c-Met signaling.
• Vascular Endothelial Growth Factor (VEGF): While primarily angiogenic, VEGF also enhances epithelial migration indirectly by improving vascular perfusion and nutrient delivery.

2. Cytokines and Chemokines

Pro-inflammatory and regulatory cytokines influence epithelialization by activating signal transduction pathways and altering gene expression:

• Interleukin-1 (IL-1) and Tumor Necrosis Factor-alpha (TNF-α): Initiate keratinocyte activation and MMP expression for ECM remodeling.
• Interleukin-6 (IL-6): Enhances keratinocyte proliferation and STAT3 activation.
• GM-CSF and IL-8: Recruit and activate immune cells, which in turn modulate the epithelial response through paracrine interactions.

3. Extracellular Matrix (ECM) Components

The composition and organization of the ECM are critical for keratinocyte adhesion, migration, and signaling. Key ECM elements include:

• Fibronectin: Early provisional matrix component that supports cell migration via α5β1 integrins.
• Laminin-332 (Laminin-5): Essential for reformation of the basement membrane and stable epithelial attachment.
• Collagen Types I, III, and IV: Structural proteins that guide migration and facilitate re-epithelialization.
• Hyaluronic Acid (HA): Provides a hydrated matrix conducive to cell movement and proliferation.

4. Integrins and Adhesion Molecules

Keratinocyte interaction with the ECM is mediated by integrins, transmembrane receptors that transmit mechanical and biochemical signals:

• α3β1, α5β1, and αvβ6 integrins: Mediate adhesion and migration over fibronectin and laminin substrates.
• Focal adhesion kinase (FAK) and Src family kinases: Activated upon integrin binding, initiating intracellular signaling cascades that regulate cell motility and survival.

5. Oxygen Tension and Nutrient Availability

Tissue oxygenation directly affects keratinocyte metabolism and proliferation:

• Hypoxia-inducible factors (HIFs): In moderate hypoxia, HIF-1α promotes VEGF expression and epithelial survival.
• Chronic hypoxia, however, impairs ATP production, cell motility, and protein synthesis, hindering epithelialization.
• Adequate levels of glucose, amino acids, and trace elements (e.g., zinc, iron, copper) are essential for supporting anabolic processes in epithelial cells.

6. Inflammatory Environment

A controlled inflammatory phase is essential for proper wound healing, but prolonged or excessive inflammation can inhibit epithelialization:

• Neutrophil-derived proteases degrade ECM and growth factors if not properly regulated.
• Persistent macrophage activation leads to elevated levels of TNF-α and reactive oxygen species (ROS), which can be cytotoxic to keratinocytes.

7. Cellular Interactions and Signaling Pathways

Complex paracrine signaling between epithelial cells, fibroblasts, immune cells, and endothelial cells orchestrates epithelialization:

• Wnt/β-catenin signaling: Regulates epithelial stem cell activation and wound-induced proliferation.
• Notch signaling: Coordinates keratinocyte differentiation and stratification.
• TGF-β/Smad signaling: Balances keratinocyte proliferation with terminal differentiation and basement membrane restoration.

Impaired Epithelialization in Chronic Wounds

In chronic wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure sores, the normal progression of epithelialization is often arrested or severely delayed. Unlike acute wounds, which undergo a rapid and organized healing process, chronic wounds are characterized by a prolonged inflammatory state, cellular dysfunction, and degraded extracellular matrix (ECM)—all of which directly impair keratinocyte function and epithelial regeneration.

1. Persistent Inflammation and Cytokine Imbalance

One of the hallmarks of chronic wounds is sustained, non-resolving inflammation. Elevated levels of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6 maintain keratinocytes in an activated state, but paradoxically inhibit their proliferation and migration.

• Neutrophil persistence leads to excessive release of proteolytic enzymes (e.g., MMP-9, elastase), which degrade ECM components and growth factors necessary for epithelial migration.
• High levels of ROS (reactive oxygen species) induce oxidative stress, DNA damage, and apoptosis in keratinocytes.

2. Keratinocyte Dysfunction

In chronic wounds, keratinocytes often exhibit reduced migratory and proliferative capacities, attributed to:

• Senescence: Cellular aging, driven by oxidative stress and metabolic imbalances, reduces responsiveness to growth factors.
• Altered signaling: Downregulation of EGFR, FGFR, and integrins compromises cytoskeletal remodeling and motility.
• Phenotypic reprogramming: Chronic wound keratinocytes may show abnormal expression of differentiation markers or remain in a partially activated, non-functional state.

3. Matrix Degradation and Loss of Substrate Integrity

The ECM in chronic wounds is typically fragmented and depleted due to excessive matrix metalloproteinase (MMP) activity and insufficient tissue inhibitor of metalloproteinases (TIMP) levels. As a result:

• Keratinocytes lack an appropriate migratory substrate.
• The basement membrane is disrupted, impairing reattachment and polarity re-establishment.
• Key ECM ligands (e.g., fibronectin, laminin-332) necessary for integrin-mediated migration are degraded.

4. Ischemia and Hypoxia

Reduced perfusion and microvascular dysfunction, common in diabetic and pressure ulcers, limit oxygen and nutrient delivery to the wound bed:

• Hypoxia below critical levels impairs ATP generation, protein synthesis, and cellular proliferation.
• Angiogenesis is disrupted, delaying granulation tissue formation and thereby stalling the epithelialization front.

5. Impaired Crosstalk with Stromal and Immune Cells

Successful epithelialization depends on dynamic interactions between keratinocytes, fibroblasts, and immune cells. In chronic wounds:

• Fibroblasts are often senescent, secreting fewer growth factors (e.g., KGF, TGF-β) needed to support keratinocytes.
• Macrophage polarization is skewed toward a persistent M1 pro-inflammatory state, with reduced M2-mediated regenerative signaling.
• Disrupted feedback loops prevent the resolution of inflammation and the transition to tissue regeneration.

6. Systemic and Comorbid Factors

A range of systemic conditions exacerbate epithelialization failure:

• Diabetes mellitus: Hyperglycemia impairs keratinocyte metabolism, increases ROS, and affects signal transduction.
• Malnutrition: Deficiencies in zinc, vitamin C, and protein compromise cell proliferation and collagen synthesis.
• Advanced age: Delays cell cycle progression and reduces stem cell activation.

Epithelialization vs. Granulation: What’s the Difference?

Epithelialization and granulation are two distinct yet interdependent processes within the broader context of wound healing. While both are critical to successful tissue repair, they involve different cell types, biological functions, and spatial roles in the wound bed. Understanding the differences—and the interplay—between these processes is essential for interpreting wound healing dynamics and designing effective therapeutic strategies.

1. Cellular Composition and Origin

• Epithelialization is primarily driven by keratinocytes, the specialized epithelial cells of the epidermis. These cells originate from the basal layer of the epidermis and skin appendages (e.g., hair follicles, sweat glands), where epithelial stem cells reside.
• Granulation tissue, on the other hand, is composed of fibroblasts, endothelial cells, macrophages, and pericytes. These cells are primarily derived from the dermis and circulating progenitor cells and contribute to stromal tissue reconstruction.

2. Function and Purpose

• The primary function of epithelialization is the reconstitution of the epidermal barrier, which protects against environmental insults, water loss, and microbial invasion.
• Granulation tissue formation is aimed at rebuilding the connective tissue matrix and restoring vascular supply. It creates a supportive scaffold for epithelial cell migration and re-epithelialization.

3. Tissue Architecture and Appearance

• Epithelial tissue formed during epithelialization is organized, stratified, and tightly bound by cell–cell junctions (e.g., desmosomes, tight junctions). It regenerates the original tissue architecture of the epidermis.
• Granulation tissue is a transient, unstructured tissue characterized histologically by:
  • Proliferating fibroblasts producing collagen and ECM components
  • Neovascularization (angiogenesis)
  • Infiltration by immune cells (macrophages, lymphocytes)
  • A reddish, granular appearance due to the rich capillary network

4. Molecular Pathways and Regulation

• Epithelialization is regulated by signals that promote keratinocyte migration, proliferation, and differentiation, including EGF, KGF, TGF-α, and Wnt/β-catenin pathways.
• Granulation tissue formation involves signaling molecules such as TGF-β, VEGF, PDGF, and FGF2, which stimulate fibroblast activation, collagen synthesis, and angiogenesis.

5. Temporal Sequence and Interdependence

• Granulation tissue typically forms before or in parallel with epithelialization, providing a provisional matrix and vascular support required for keratinocyte migration.
• Without adequate granulation, epithelial cells may lack the substrate and trophic support necessary for successful re-epithelialization.
• Conversely, once epithelialization is complete, granulation tissue begins to regress during the remodeling phase, replaced by mature dermal tissue and extracellular matrix.

References:

1. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008 May 15;453(7193):314-21. doi: 10.1038/nature07039
2. Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med. 2014 Dec 3;6(265):265sr6. doi: 10.1126/scitranslmed.3009337. 
3. Guo, S., & DiPietro, L. A. (2010). Factors affecting wound healing. Journal of Dental Research, 89(3), 219–229. https://doi.org/10.1177/0022034509359125
4. Shaw, T. J., & Martin, P. (2009). Wound repair at a glance. Journal of Cell Science, 122(18), 3209–3213. https://doi.org/10.1242/jcs.031187
5. Takeo, M., Lee, W., & Ito, M. (2015). Wound healing and skin regeneration. Cold Spring Harbor Perspectives in Medicine, 5(1), a023267. https://doi.org/10.1101/cshperspect.a023267

FAQs